NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
Upcoming Events
There are no upcoming events scheduled at this time. Sign up here to receive notices about upcoming events and press releases.
NOW APPROVED
Journey Medical Corporation Announces the U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg for Treatment of Papulopustular Rosacea.
IR Calendar
We use cookies to offer you a better browsing experience, including personalized advertising. By continuing to use the site you agree to their use.